USP Monograph Could Substitute For ANDA Chemistry Review, Williams Says
Executive Summary
Chemistry reviews for ANDAs conforming to a USP monograph could be eliminated, U.S. Pharmacopoeia CEO-designate Roger Williams, MD, told the National Association of Pharmaceutical Manufacturers annual meeting.